MENU
CARA
Stock ticker:
PRICE
CHANGE
CAPITALIZATION
Cara Therapeutics (CARA) Ownership - Who owns Cara Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
400 Atlantic Street
Phone
+1 203 406-3700
Employees
55
Web
https://www.caratherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
16.89M
P/E Ratio
N/A
Total Cash
56.62M
Projected Growth
N/A
Total Debt
7.49M
Revenue
11M
Risk (Beta)
0.63
Dividend Yield
N/A
Total Cash/Share
1.03
Total Debt/Equity
N/A
Revenue/Share
0.20 USD as % of share price
Fundamentals
CARA
Capitalization
16.9M
P/E Ratio
N/A
Risk (Beta)
0.63
Dividend Yield
N/A
Total Cash
56.6M
Total Cash/Share
1.03
Total Debt
7.49M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.20%
Revenue
11M
ROE
N/A
Book Value
11.6M
P/B Ratio
1.46
Cash Flow
N/A
Earnings
-2.04
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
54K
Current Ratio
4.59
Current Revenue Per Employee
18018.18
Dividends Per Share - Security
N/A
EBITDA
-106.33M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-107.38
Shares Held By Institutions
11.1M
Shares Outstanding - Current
54.8M
Total Liabilities
60.9M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-64.334
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of pharmaceutical products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
400 Atlantic Street
Phone
+1 203 406-3700
Employees
55
Web
https://www.caratherapeutics.com